Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Bone. 2019 Jul 2;127:386–392. doi: 10.1016/j.bone.2019.06.025

Table 3:

Nephrocalcinosis and Renal Function in relation to Hyperparathyroidism

Category Tertiary hyperparathyroidism Secondary hyperparathyroidism Patients without any hyperparathyroidism All patients without tertiary hyperparathyroidism p value (comparing tertiary hyperparathyroidism to other groups)
Nephrocalcinosis prevalence 6/10 (60.0%) 7/48 (14.6%) 4/11 (36.4%) 11/59 (18.6%) p=0.005 (secondary)
p=0.26 (normal)
p=0.011 (all)
eGFR <60 mL/min/1.732 5/14 (35.7%) 1/56 (1.8%) 0/14 (0%) 1/69 (1.5%) p=0.009 (secondary)
p=0.025 (normal)
p=0.004 (all)